Rheumatology News

Secondhand cigarette smoke increases the risk for developing rheumatoid arthritis, but only in cases of low-level exposure, according to data published in Scientific Reports.

The monoclonal antibody Uplizna met key endpoints in a phase 3 trial for the treatment of IgG4-related disease, marking the first time a placebo-controlled study has shown benefit in the condition, according to a press release from Amgen.

Much of the mortality in rheumatic heart disease was attributable to heart failure, and was significantly reduced by interventional treatment, which may stand as a barrier to improving mortality in lower-income countries, data show.

In this Healio video exclusive, Michael S. Garshick, MD, MS, discusses the role of inflammation in heart disease and how it has become a treatment target.

Older adults with arthritis demonstrate poorer nutritional risk scores, and increased risks for poor nutrition, whether they have functional impairment or not, vs. those without arthritis, according to data published in Scientific Reports.

The FDA has expanded the indication of Rinvoq to include active, polyarticular juvenile idiopathic arthritis and psoriatic arthritis in children aged 2 years and older, according to an AbbVie press release.

Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.

New definitions of remission specific to childhood systemic lupus erythematosus promote cessation of corticosteroids and could enable combined child-adult treat-to-target studies, according to an analysis published in Clinical Immunology.

Self-administered acupressure, combined with a short education program, was a cost-effective method of pain relief that boosted mobility in adults with probable knee osteoarthritis, according to data published in JAMA Network Open.

BOSTON — The percentage of women with osteoporosis who also had diabetes increased from 2009-2010 to 2017-2018, despite a decline in overall diabetes rates for women aged 50 years and older, according to data presented at ENDO 2024.